M. Tynan

Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.

Michael J Schell, Martha Moore, Ji-Hyun Lee, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.

M. Socinski, F. Detterbeck, T. Hensing, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I/II trial of weekly docetaxel and gefitinib in elderly patients with stage IIIB/IV non-small cell lung cancer.

M. Socinski, T. Stinchcombe, P. Bůžková, 2006, Lung cancer.

Second-line gemcitabine in refractory stage IV non small-cell lung cancer: a phase II trial.

M. Socinski, M. Schell, M. Tynan, 2000, Clinical lung cancer.

Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.

M. Socinski, M. Schell, D. Garfield, 2003, Lung cancer.

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.

M. Socinski, J. Beaumont, A. Peterman, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.